Loading clinical trials...
Loading clinical trials...
In this observational cohort study, the researchers propose to first identify a psychophysiological marker of methamphetamine cue-reactivity and its incubation with abstinence from methamphetamine use...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NCT06899594 · Methamphetamine Use Disorder
NCT06532370 · Contingency Managment, Methamphetamine Use Disorder
NCT05322954 · Methamphetamine Use Disorder, Substance-Related Disorders, and more
NCT07221396 · Stimulant Use Disorder, Cocaine Use Disorder, and more
NCT07399431 · Methamphetamine Use Disorder, Theta Burst Stimulation, and more
Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions